E-media
HEALTH
September 22nd, 2007
Less Bureaucracy And Over-Management Are Key To Furthering
World Class Cancer Research In Europe
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation’s
second survey, which looks at the overall €3.2
billion cancer research spend for 2004, at the European
Parliament today (Tuesday 18 September).
All Drugs Info.com
September 22nd, 2007
Statement
By The Minister For Health & Children Mary
Harney, T.D. On Cancer Research, Ireland
Commenting on the publication of the European Cancer Research
Managers Forum moment European Survey the Minister for
Health and Children, Mary Harney T.D. said: “This
report analyses how cancer research is funded and enables
us to monitor our progress in cancer research funding in
relation to our Eu…
alphagalileo
4 September 2007
Launch of second European Cancer Research Funding Survey
Less bureaucracy and over-management are key to furthering
world class cancer research in Europe
Brussels: The second European survey [1] analysing how
cancer research is funded
shows that contrary to public perception Europe is a major
contributor to the global
cancer research effort.
Medical News Today
22 Sep 2007
Statement
By The Minister For Health & Children Mary
Harney, T.D. On Cancer Research, Ireland
Commenting on the publication of the European Cancer Research
Managers Forum Second European Survey the Minister for
Health and Children, Mary Harney T.D. said: "This
report analyses how cancer research is funded and enables
us to monitor our progress in cancer research funding in
relation to our European counterparts."
World Pharma News
Thursday, 20 September 2007
Spending on Cancer Research
in Europe Rising
Spending on cancer research in Europe is on the up, and
Europe is now a major contributor to the global cancer
research effort, according to the second cancer research
funding survey by the European Cancer Research Managers
(ECRM) Forum. However, growing levels of bureaucracy threaten
to stifle future research, the report warns.
Medical Exchange.com
Wed, 19 September 2007
Launch of second European Cancer Research Funding survey
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
E Commerce Times
Sep-18-07
Launch of second European Cancer Research Funding survey
Brussels: The second European survey [1] analysing how
cancer research is funded shows that contrary to public
perception Europe is a major contributor to the global
cancer research effort.
“Contrary to public perception, a phenomenal amount of cancer research
is carried out in Europe, evidenced by the huge amount of cancer research papers
being published here,” said Prof Sullivan. “This is important,
as many policy...
RxPG News
Sep 18, 2007
Launch of second European Cancer Research Funding survey
He continued by making a special plea to those EU countries
which lag behind the 15 Member States which carry out the
majority of the research.
New Europe
21 September 2007 - Issue : 748
A complaint that Ireland is not taking cancer seriously
“While other countries in Europe are investing ever higher levels of
effort and money into finding ways to control and cure the disease, Ireland
is not taking cancer research seriously,” an Irish Member of the European
Parliament (MEP) said.
The Irish MEP was speaking at the launch of a key report
on cancer research funding in Europe and the USA which
took place in the European Parliament in Brussels on September
18. The report was compiled by the independent European
Cancer Research Managers Forum.
EU Business
19 September 2007
Cancer research spending on the rise in Europe: study
Spending on cancer research in Europe is on the up, and
Europe is now a major contributor to the global cancer
research effort, according to the second cancer research
funding survey by the European Cancer Research Managers
(ECRM) Forum. However, growing levels of bureaucracy threaten
to stifle future research, the report warns.
SiloBreaker
Tuesday, September 18, 2007
European Cancer Research Managers Forum (ECRM): Less bureaucracy
and over-management are key to furthering world class cancer
research in Europe
Managers Forum (ECRM): Less bureaucracy and over-management
are key to furthering world class cancer research in
MediNews
Less Bureaucracy And Over-Management Are Key To Furthering
World Class Cancer Research In Europe
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation's second
survey, which looks at the overall €3.2
billion cancer research spend for 2004, at the European
Parliament today (Tuesday 18 September).
Labour Online
September 18, 2007
A
key report about cancer research funding in Europe and
the USA has been launched at the European Parliament
in Brussels this week.
The host of the event, Local
Labour Euro MP, Arlene McCarthy who Chair’s the European Parliament’s Internal
Market & Consumer Protection Committee and is an active
cancer awareness campaigner, has welcomed the report, she
said:
"The report gives EU policy
makers a clearer picture of the cancer research environment
at a time when cancer is being given increasing importance
on the agenda of European and national policy makers."
TechNewsWorld
Sep-18-07
EurekAlert: Launch of second European Cancer Research Funding
survey
Summary: "Brussels: The second European survey [1] analysing
how cancer research is funded shows that contrary to public
perception Europe is a major contributor to the global
cancer research effort...
"Contrary to public perception, a phenomenal amount
of cancer research is carried out in Europe, evidenced
by the huge amount of cancer research papers being published
here," said Prof Sullivan. "This is important,
as many policy...
Cordis
Date: 2007-09-19
Spending on cancer research rising, study shows
Spending on cancer research in Europe is on the up, and
Europe is now a major contributor to the global cancer
research effort, according to the second cancer research
funding survey by the European Cancer Research Managers
(ECRM) Forum. However, growing levels of bureaucracy threaten
to stifle future research, the report warns.
DIGG
18 Sep, 2007
Spending on Cancer Research in Europe Rising
Spending on cancer research in Europe is on the up, and
Europe is now a major contributor to the global cancer
research effort, according to the second cancer research
funding survey by the European Cancer Research Managers
(ECRM) Forum. However, growing levels of bureaucracy threaten
to stifle future research, the report warns.
Innovations Report
18.09.2007
Launch of second European Cancer Research Funding Survey
Less bureaucracy and over-management are key to furthering
world class cancer research in Europe
Brussels: The second European survey [1] analysing how
cancer research is funded shows that contrary to public
perception Europe is a major contributor to the global
cancer research effort.
Rootly
Tuesday, Sept. 18
Launch of second European Cancer Research Funding survey
The second European survey analyzing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.Professor
Richard Sullivan, chair of the European Cancer Research
Managers Forum, launched the organization's second survey,
which looks at the overall 3.2 billion cancer research
spend for 2004, at the European Parliament today
NewsonFeeds
Tue, sep 18 2007
Launch of second European Cancer Research Funding survey
The second European survey analyzing
how cancer research is funded shows that contrary to
public perception Europe is a major contributor to the
global cancer research effort.Professor Richard Sullivan,
chair of the European cancer research Managers Forum,
launched the organization's second survey, which looks
at the overall €3.2 billion cancer research
spend for 2004, at the European Parliament.
MacNewsWorld
Sep-18-07
Launch of second European Cancer Research Funding survey
Brussels: The second European survey [1] analysing how
cancer research is funded shows that contrary to public
perception Europe is a major contributor to the global
cancer research effort.
“Contrary to public perception, a phenomenal amount
of cancer research is carried out in Europe, evidenced
by the huge amount of cancer research papers being published
here,” said Prof Sullivan. “This is important,
as many policy...
R X Journal
September 18th, 2007
Less Bureaucracy And Over-Management Are Key To Furthering
World Class Cancer Research In Europe
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation’s
second survey, which looks at the overall‚ €3.2
billion cancer research spend for 2004, at the European
Parliament today.
Medical Lead
September 18th, 2007
Less Bureaucracy And Over-Management Are Key To Furthering
World Class Cancer Research In Europe
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation’s
second survey, which looks at the overall
Med Peak.com
Less Bureaucracy And Over-Management Are Key To Furthering
World Class Cancer Research In Europe
The second European survey [1] analysing how cancer research
is funded shows that contrary to public perception Europe
is a major contributor to the global cancer research effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation’s
second survey, which looks at the overall
American College of Emergency Physicians
Europe Closing Gap on United States in Cancer Research,
Survey Finds
... research spending between 2003 and 2004, although the
United States still spends many times more per person and
as a share of gross domestic product, according to a survey
published Sept. 18. The European Cancer Research Managers
Forum. ACEP & Elsevier Top Stories daily news.
SoapBox Ireland
Tuesday, September 18, 2007
Ireland lagging in cancer research funding
The author of a report into cancer research funding across
Europe has said Ireland is punching below its weight on
funding and is being overtaken by other countries.
Cancer Research UK
TUESDAY 18 SEPTEMBER 2007
EU member states urged to support research
Professor Richard Sullivan, chair of the European Cancer
Research Managers Forum (ECRM), has urged all EU member
states to support cancer research.
Professor Sullivan, who is also Cancer Research UK's director
of clinical programmes, said reducing the levels of bureaucracy
and over-management would be key to furthering world-class
cancer research.
The Guardian (Ireland)
Saturday October 13 2007
MEP Burke critical of cancer research spend
'Despite our growing wealth, Ireland is not increasing
its per capita spend on cancer research.' Speaking at the
launch of the European Cancer Research Managers Forum report
in the European Parliament in Brussels, Fine Gael MEP Colm
Burke said: 'We need to ask ourselves do we have our priorities
right.' The report, which compared the EU and the USA as
well as looking ...
First Science
18 Sep 2007
Launch of second European Cancer Research Funding survey
Less bureaucracy and over-management are key to furthering
world class cancer research in Europe
Brussels: The second European survey analysing how cancer
research is funded shows that contrary to public perception
Europe is a major contributor to the global cancer research
effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation’s
second survey, which looks at the overall €3.2 billion
cancer research spend for 2004, at the European Parliament
today (Tuesday 18 September).
EU Buisness
19 September 2007, 18:41 CET
Cancer research spending on the rise in Europe: study
Spending on cancer research in Europe is on the up, and
Europe is now a major contributor to the global cancer
research effort, according to the second cancer research
funding survey by the European Cancer Research Managers
(ECRM) Forum. However, growing levels of bureaucracy threaten
to stifle future research, the report warns.
Silo Breaker
09/18/2007
European Cancer Research Managers Forum (ECRM): Less bureaucracy
and over-management are key to furthering world class cancer
research in Europe
Brussels: The second an survey [1]analysing how cancer
research is funded shows that contrary to public perception
Europe is a major contributor to the global cancer research
effort.
Association of Online Cancer Resources
Sep 18, 2007
Launch of second European Cancer Research Funding survey
Less bureaucracy and over-management are key to furthering
world class cancer research in Europe
Brussels: The second European survey [1] analysing how
cancer research is funded shows that contrary to public
perception Europe is a major contributor to the global
cancer research effort.
Calibre
Tuesday, September 18, 2007 7:35 AM
European Cancer Research Managers Forum (ECRM): Less bureaucracy
and over-management are key to furthering world class cancer
research in Europe
Brussels: The second European survey [1]analysing how cancer
research is funded shows that contrary to public perception
Europe is a major contributor to the global cancer research
effort.
Prof Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation's second
survey, which looks at the overall EUR3.2 billion cancer
research spend for 2004, at the European Parliament today
(Tuesday 18 September).
Innovations Report
18.09.2007
Launch of second European Cancer Research Funding Survey
Less bureaucracy and over-management are key to furthering
world class cancer research in Europe. Brussels: The second
European survey [1] analysing how cancer research is funded
shows that contrary to public perception Europe is a major
contributor to the global cancer research effort.
All American Patriots
Over-management are key to furthering world class cancer
research in Europe
18-Sep-2007, Brussels -- The second European survey [1]
analysing how cancer research is funded shows that contrary
to public perception Europe is a major contributor to the
global cancer research effort. Prof Richard Sullivan, chair
of the European Cancer Research Managers...
Drug Researcher
18/09/2007
UK set to overtake US on cancer funding
By Mike Nagle
- A new survey has shown that the cancer research funding
gap between the US and Europe is narrowing, with the UK
is set to become the world leader on a per capita basis.
Prof. Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation's second
survey at the European Parliament this morning, which examines
how the €3.2bn spent in Europe on cancer research
in 2004 was used.
US Pharma
18/09/2007
A new survey has shown that the cancer research funding
gap between the US and Europe is narrowing, with the UK
is set to become the world leader on a per capita basis.
Prof. Richard Sullivan, chair of the European Cancer Research
Managers Forum (ECRM), launched the organisation's second
survey at the European Parliament this morning, which examines
how the €3.2bn spent in Europe on cancer research
in 2004 was used.
Lab Technologist
18/09/2007
A new survey has shown that the cancer research funding
gap between the US and Europe is narrowing, with the UK
is set to become the world leader on a per capita basis.
Prof. Richard Sullivan, chair of
the European Cancer Research Managers Forum (ECRM), launched
the organisation's second survey at the European Parliament
this morning, which examines how the €3.2bn spent
in Europe on cancer research in 2004 was used.
NewsFood
20/09/2007
Da uno studio emerge l'aumento della spesa per la ricerca
sul cancro
In base all'indagine, avviata il 18 settembre al Parlamento
europeo, nel 2004 in Europa sono stati spesi 3,2 Mrd EUR
per la ricerca sul cancro, un incremento del 38% rispetto
all'ultimo studio risalente a due anni fa
CyberMed
martedì 18 settembre 2007
CANCRO: UE, CRESCITA RECORD DEI FINANZIAMENTI RICERCA
Inviato da Cybermed
Bruxelles - Si accorciano le distanze tra Europa e Usa
sul fronte dei finanziamenti alla ricerca scientifica sul
cancro. I datisono stati presentati oggi a Bruxelles allo
European Cancer Research Managers Forum (ECRM), e sono
relativi allaseconda indagine sui finanziamenti alla ricerca
che ha analizzato come sono stati speso 3 miliardi e 200
milioni di euronel 2004 per la ricerca oncologica. Secondo
l'inchiesta in Europa operano 155 organizzazioni pubbliche
che hannodestinato in media 1 milione e 971 mila euro alla
ricerca oncologica, contro i 5milioni degli Usa.Rispetto
a due anni fa, quando e' stata condotta la prima indagine,
i finanziamenti nell'Ue sono aumentati del 38 per
cento, mentre negli Usa sono rimasti uguali. "Dalla
prima indagine, circa il 60 per cento dei paesi membri
haincrementato i finanziamenti alla ricerca oncologica,
mentre il 30 per cento li hanno mantenuti allo stesso livello",
hadetto Richard Sullivan, presidente del Forum. Tuttavia,
per incoraggiare la ricerca e la collaborazione internazionalesarebbe
necessario snellire la burocrazia, che imbriglia la ricerca
in eccessive regolamentazioni. Il rapporto inoltre hastimato
per la prima volta la spesa annuale delle principali aziende
farmaceutiche europee:, che investono poco piu' di 3 milioni
all'anno per la ricerca sul cancro, circa il 22 per cento
della spesa globale. "Tradizionalmente l'Europa
e' stataconsiderata debole nell'attirare investimenti industriali
in ricerca e sviluppo. In realta', le aziende farmaceutiche
europeeattirano circa il 45,9 per cento della spesa farmaceutica
per tutte le malattie". Fonte: Agi/Federfarma
RaiNet News
18/09/2007 13:02
Ue, crescita record dei finanziamenti per la ricerca sul
cancro
Il 60% dei Paesi membri ha aumentato le risorse per l’oncologia.
Cresce anche la spesa farmaceutica europea in ricerca e
sviluppo
Si accorciano le distanze tra Europa e Usa sul fronte dei
finanziamenti alla ricerca scientifica sul cancro. I dati
sono stati presentati a Bruxelles all’ European Cancer
Research Managers Forum (ECRM), e sono relativi alla seconda
indagine sui finanziamenti alla ricerca che ha analizzato
come sono stati spesi 3 miliardi e
200 milioni di euro nel 2004 per la ricerca oncologica.
Secondo l'inchiesta, in Europa operano 155 organizzazioni
pubbliche che hanno destinato in media 1 milione e 971
mila euro alla ricerca oncologica, contro i 5milioni degli
Usa. Rispetto a due anni fa, quando è stata condotta
la prima indagine, i finanziamenti nell'Ue erano aumentati
del 38 per cento, mentre negli Usa rimanevano
uguali.
AGI Salute
Ue, crescita record finanziamenti a ricerca
(AGI) - Bruxelles - Si accorciano le distanze tra Europa
e Usa sul fronte dei finanziamenti alla ricerca scientifica
sul cancro. I dati sono stati presentati oggi a Bruxelles
allo European Cancer Research Managers Forum (ECRM), e
sono relativi alla seconda indagine sui finanziamenti alla
ricerca che ha analizzato come sono stati speso 3 miliardi
e 200 milioni di euro nel 2004 per la ricerca oncologica.
Secondo l'inchiesta in Europa operano 155 organizzazioni
pubbliche che hanno destinato in media 1 milione e 971
mila euro alla ricerca oncologica, contro i 5milioni degli
Usa. Rispetto a due anni fa, quando e' stata condotta la
prima indagine, i finanziamenti nell'Ue sono aumentati
del 38 per cento, mentre negli Usa sono rimasti uguali. "Dalla
prima indagine, circa il 60 per cento dei paesi membri
ha incrementato i finanziamenti alla ricerca oncologica,
mentre il 30 per cento li hanno mantenuti allo stesso livello",
ha detto Richard Sullivan, presidente del Forum. Tuttavia,
per incoraggiare la ricerca e la collaborazione internazionale
sarebbe necessario snellire la burocrazia, che imbriglia
la ricerca in eccessive regolamentazioni. Il rapporto inoltre
ha stimato per la prima volta la spesa annuale delle principali
aziende farmaceutiche europee:, che investono poco piu'
di 3 milioni all'anno per la ricerca sul cancro, circa
il 22 per cento della spesa globale. "Tradizionalmente
l'Europa e' stata considerata debole nell'attirare investimenti
industriali in ricerca e sviluppo. In realta', le aziende
farmaceutiche europee attirano circa il 45,9 per cento
della spesa farmaceutica per tutte le malattie".(AGI)
|
